DK0596203T3 - Præparater i fast partikelform indeholdende aktive forbindelser og vandopløselige polymerer - Google Patents

Præparater i fast partikelform indeholdende aktive forbindelser og vandopløselige polymerer

Info

Publication number
DK0596203T3
DK0596203T3 DK93112464T DK93112464T DK0596203T3 DK 0596203 T3 DK0596203 T3 DK 0596203T3 DK 93112464 T DK93112464 T DK 93112464T DK 93112464 T DK93112464 T DK 93112464T DK 0596203 T3 DK0596203 T3 DK 0596203T3
Authority
DK
Denmark
Prior art keywords
water
active compounds
containing active
compositions containing
soluble polymers
Prior art date
Application number
DK93112464T
Other languages
Danish (da)
English (en)
Inventor
Axel Dr Sanner
Sven Dr Grabowski
Joerg Dr Rosenberg
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK0596203T3 publication Critical patent/DK0596203T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK93112464T 1992-08-13 1993-08-04 Præparater i fast partikelform indeholdende aktive forbindelser og vandopløselige polymerer DK0596203T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226753A DE4226753A1 (de) 1992-08-13 1992-08-13 Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen

Publications (1)

Publication Number Publication Date
DK0596203T3 true DK0596203T3 (da) 2000-03-13

Family

ID=6465437

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93112464T DK0596203T3 (da) 1992-08-13 1993-08-04 Præparater i fast partikelform indeholdende aktive forbindelser og vandopløselige polymerer

Country Status (12)

Country Link
US (1) US5641516A (no)
EP (1) EP0596203B1 (no)
JP (1) JPH06172160A (no)
AT (1) ATE186638T1 (no)
AU (1) AU661407B2 (no)
CA (1) CA2103961C (no)
DE (2) DE4226753A1 (no)
DK (1) DK0596203T3 (no)
ES (1) ES2140428T3 (no)
GR (1) GR3031871T3 (no)
MX (1) MX9304658A (no)
NO (1) NO307811B1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ291495B6 (cs) 1992-09-18 2003-03-12 Yamanouchi Pharmaceutical Co., Ltd. Hydrogelotvorný farmaceutický přípravek s prodlouženým uvolňováním
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
WO1995031900A1 (fr) * 1994-05-24 1995-11-30 Nippon Shinyaku Co., Ltd. Composition pesticide et procede pour sa preparation
FR2725624B1 (fr) * 1994-10-14 1997-01-17 Jouveinal Inst Rech Procede de preparation de formes pharmaceutiques a liberation controlee
DE19504831A1 (de) * 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
SI9500173B (sl) * 1995-05-19 2002-02-28 Lek, Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
DE19531277A1 (de) 1995-08-25 1997-02-27 Basf Ag Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
DE19531684A1 (de) * 1995-08-29 1997-03-06 Bayer Ag Verfahren zur Herstellung von Arzneimittelzubereitungen mit kontrollierter Freisetzung
HU227745B1 (en) * 1996-05-20 2012-02-28 Janssen Pharmaceutica Nv Antifungal compositions containing itraconazole
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
HN1998000115A (es) * 1997-08-21 1999-06-02 Warner Lambert Co Formas de dosificación farmacéuticas sólidas
IL135664A0 (en) * 1997-10-29 2001-05-20 Basf Ag Solid formulation of a plant protection agent
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
DE19934610A1 (de) * 1999-07-23 2001-01-25 Bayer Ag Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
EP1175205B1 (en) * 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE10215147A1 (de) * 2002-04-05 2003-10-16 Basf Ag Verwendung von Polymerisation, enthaltend thermoplastische Polymere als Filterhilfs- und/oder Stabilisierungsmittel
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient
KR101082774B1 (ko) 2006-04-12 2011-11-11 닛뽕소다 가부시키가이샤 서방성 정제의 제조 방법
ITPI20060098A1 (it) 2006-07-28 2008-01-29 Antonio Maccari Sistema di controllo della funzionalita' degli ugelli di una testina di stampa.
EP2112925A4 (en) * 2006-11-15 2013-01-09 Abbott Lab SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
JP6854162B2 (ja) * 2017-03-17 2021-04-07 ライオン株式会社 錠剤
TWI692499B (zh) * 2019-07-19 2020-05-01 怡定興科技股份有限公司 用於微針貼片之針底組成物及包含其之微針貼片

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636865A (no) * 1962-08-31
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
US4832957A (en) * 1987-12-11 1989-05-23 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814168A (en) * 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
DE3830353A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
US5273760A (en) * 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer

Also Published As

Publication number Publication date
MX9304658A (es) 1994-02-28
CA2103961A1 (en) 1994-02-14
AU661407B2 (en) 1995-07-20
EP0596203B1 (de) 1999-11-17
AU4457293A (en) 1994-02-17
DE4226753A1 (de) 1994-02-17
DE59309876D1 (de) 1999-12-23
EP0596203A1 (de) 1994-05-11
US5641516A (en) 1997-06-24
NO932875D0 (no) 1993-08-12
ES2140428T3 (es) 2000-03-01
NO307811B1 (no) 2000-06-05
ATE186638T1 (de) 1999-12-15
GR3031871T3 (en) 2000-02-29
NO932875L (no) 1994-02-14
JPH06172160A (ja) 1994-06-21
CA2103961C (en) 2005-08-09

Similar Documents

Publication Publication Date Title
DK0596203T3 (da) Præparater i fast partikelform indeholdende aktive forbindelser og vandopløselige polymerer
ES2117829T3 (es) Composicion de catalizador de metaloceno cargada y secada por pulverizacion, utilizada en la fabricacion de poliolefinas.
CA2220871A1 (en) Peptide/protein suspending formulations
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
DK0386967T3 (da) Coatingmateriale til styring af lægemiddelafgivelse i langtidsvirkende formuleringer
DE3886608D1 (de) Verfahren zur Herstellung von ultrahochmolekularen Polyolefinen.
ATE420630T1 (de) Pulverzubereitungen und verfahren zu ihrer herstellung
FI945476A0 (fi) Hitaasti vapautuvat koostumukset ja menetelmä farmaseuttisten koostumusten valmistamiseksi
CA2112010A1 (en) (Cyclo)Aliphatic Epoxy Compounds
CA2055594A1 (en) Percutaneous lymphography
EP0373633A3 (en) Polyetheric copolymers, process for preparing the same, compositions containing the same, their molded products, and their use
KR880700666A (ko) 신규 흡입용 제약 조성물
ATE45283T1 (de) Zusammensetzungen fuer die herstellung von mikropartikeln durch extrusion fuer verzoegerte abgabe von biologisch aktiven substanzen und so erhaltene mikropartikel.
ES8500971A1 (es) Procedimiento para la preparacion de un granulado de polimero
FI945878A (fi) Menetelmä kompaktien pesuainekoostumusten valmistamiseksi
FR2720402B1 (fr) Compositions destinées au marquage des matériaux plastiques par irradiation laser, leur procédé de préparation, mélanges maîtres les contenant et leur application dans le marquage laser des plastiques.
ATE238070T1 (de) Komplex aus carrageenan und einem wasserlöslichen medikament mit einer spezifischen granulometrie und entsprechende pharmazeutische zusammensetzungen mit gesteuerter freisetzung
ATE28400T1 (de) Presslinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung.
DK0436252T3 (da) Farmaceutisk præparat til oral administration i flydende form
DK0619113T3 (da) Til affarvning af hår anvendelig granulær peroxidsammensætning og fremgangsmåde til fremstilling deraf
ATE127138T1 (de) Dispergierte teilchen enthaltende überzugszusammensetzungen und verfahren zu deren herstellung.
EP0238876A3 (en) Silica-containing polyorganosiloxane compositions
JPS5730724A (en) Polymer having disulfide bond in molecule and its preparation
Rashidbaigi et al. [46] Binding of 32P-labeled human recombinant immune interferon to U937 cells
Nairn Important Properties Divergencies